At Target Field, every Sunday is Kid’s Day and on a beautiful summer day in August of 2019, Samuel Anastos scored the first honorary run of a Minnesota Twins game. It was a joyous moment made all the more meaningful because there was a time in Sam’s life when his parents questioned whether he would learn to walk or talk, much less run.

The U.S. Food Drug Administration’s (FDA’s) recent approval of a new oral medication to help treat spinal muscular atrophy (SMA) is being hailed as a “game changer” by Gillette Children's Specialty Healthcare neurologist, Randal Richardson, MD, MMS. “The main message I want to get out to people who have SMA and their families is—many of you now have options and the power to make a choice for yourself,” Richardson says.

There's a new level of excitement and commitment to conducting research at Gillette that could change and improve the lives of countless numbers of children everywhere, and donor support is pivotal in leading the charge. 

For 123 years the doctors, nurses and employees at Gillette have worked every day to provide the very best care for all children. This dedication has led to treatments and outcomes that have influenced cerebral palsy care worldwide. 

The hospital can be a scary place for anyone, especially a child, and no matter how nice the staff is or how thoughtfully the clinical spaces are designed, it’s usually difficult for a patient to forget they’re in one. At Gillette Children’s Specialty Healthcare, that’s no longer the case.

The Fred C. and Katherine B. Andersen Foundation awarded Gillette a generous grant to help expand Gillette Children’s Specialty Healthcare’s spine program. This is the largest grant we’ve ever received.

All babies born in Minnesota are now being screened for spinal muscular atrophy (SMA) unless their parents opt out of the newborn screening, the Minnesota Department of Health recently announced. SMA is the leading genetic cause of early childhood death in the United States.

“I don’t think it would surprise anyone to learn that a lot of children love dogs,” says Emily DeBreto. “While we’ve had volunteers bring in therapeutic dogs at the hospital for comfort, we wanted to get our dogs more involved with the actual functional aspects of the therapy we’re providing.”

Anna Hendricksen held her breath and spent hours in suspended hope as pediatric neurologist Randal Richardson, MD, and his team assessed her daughter, Annika, to determine if she met the criteria to participate in the clinical trial for Spinraza ™, also called nusinersen, a drug to treat spinal muscular atrophy (SMA).

Pain affects all aspects of life, but for many of us, it’s an abstract concept. But, for a moment, imagine what it would feel like to experience chronic pain for an entire month. Start with that, but now expand it out to a year—or maybe even, every day of your life.

Gillette Children's Specialty Healthcare is playing a key role in the clinical trials and research into the drug Spinraza, also called nusinersen.The drug is being celebrated as the first real hope for people who have spinal muscular atrophy (SMA).

Many children and teens who have disabilities require orthotics, prosthetics and seating services to help manage their conditions. Bradley Fisher, manager in the Orthotics, Prosthetics and Seating Department at Gillette explains the process for creating orthotics, prosthetics and seating devices such as braces, limbs and CranioCaps during a Facebook LIVE tour.

A Phase II study (NNZ-2566) of a drug called Trofinetide has potential to minimize the symptoms of Rett syndrome. Learn more and meet one family who is dedicated to moving Rett syndrome research forward.

Meet HAL. He has a pulse; he breathes, blinks, and speaks numerous languages. If need be, he bleeds. This will likely be one of the stranger things you read today.

Gillette recently hosted a Facebook Live video Q&A featuring John Garcia, MD, sleep medicine specialist, about back-to-school sleep issues. Learn more and watch the discussion.

A significant portion of children who have chronic care conditions – many of whom are already on numerous medications – might benefit from the low-risk and non-toxic benefits of acupuncture.

Amanda Morcomb’s twins, Teagan and Orion, were diagnosed with plagiocephaly, or flat head syndrome, at 5 months old. Learn how the Gillette CranioCap® orthosis helped successfully round the babies’ heads—and why 3D printing means babies can begin wearing their helmets sooner.

Learn how a nurse-led initiative called family-centered rounding is improving communication between providers, nurses and families.

As we continue celebrating Nurses Week 2016, here's a look at how Gillette nurses are finding new ways to help families understand and manage their children's medications, both inside and outside the hospital.

“When I was a kid in the hospital, the nurses and registration staff remembered my name when I’d do my check-ups, and that always made me feel welcome. It’s incredible to think that now I’m on the other side of the desk recognizing families by name…it’s come full circle.” –Ed Jenkins